CN201331529Y - 丙型肝炎病毒IgM抗体快速检测试纸 - Google Patents
丙型肝炎病毒IgM抗体快速检测试纸 Download PDFInfo
- Publication number
- CN201331529Y CN201331529Y CNU2008200745974U CN200820074597U CN201331529Y CN 201331529 Y CN201331529 Y CN 201331529Y CN U2008200745974 U CNU2008200745974 U CN U2008200745974U CN 200820074597 U CN200820074597 U CN 200820074597U CN 201331529 Y CN201331529 Y CN 201331529Y
- Authority
- CN
- China
- Prior art keywords
- film
- hcv
- pad
- line
- sample pad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 53
- 241000711549 Hepacivirus C Species 0.000 title claims abstract description 10
- 239000000427 antigen Substances 0.000 claims abstract description 28
- 102000036639 antigens Human genes 0.000 claims abstract description 28
- 108091007433 antigens Proteins 0.000 claims abstract description 28
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims abstract description 10
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 9
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 9
- 238000003908 quality control method Methods 0.000 claims abstract description 6
- 238000001514 detection method Methods 0.000 claims description 14
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 230000008521 reorganization Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000003365 glass fiber Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 101710172711 Structural protein Proteins 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 19
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 229940079938 nitrocellulose Drugs 0.000 abstract 6
- 230000028993 immune response Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 description 17
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000003317 immunochromatography Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NMWONDKHBZEDMY-UHFFFAOYSA-H [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] Chemical compound [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] NMWONDKHBZEDMY-UHFFFAOYSA-H 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010019791 Hepatitis post transfusion Diseases 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNU2008200745974U CN201331529Y (zh) | 2008-04-30 | 2008-04-30 | 丙型肝炎病毒IgM抗体快速检测试纸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNU2008200745974U CN201331529Y (zh) | 2008-04-30 | 2008-04-30 | 丙型肝炎病毒IgM抗体快速检测试纸 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN201331529Y true CN201331529Y (zh) | 2009-10-21 |
Family
ID=41224913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNU2008200745974U Expired - Lifetime CN201331529Y (zh) | 2008-04-30 | 2008-04-30 | 丙型肝炎病毒IgM抗体快速检测试纸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN201331529Y (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103575884A (zh) * | 2012-07-25 | 2014-02-12 | 上海纽卓生物科技有限公司 | 胶体金法丙型肝炎病毒(hcv)快速诊断试剂盒 |
-
2008
- 2008-04-30 CN CNU2008200745974U patent/CN201331529Y/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103575884A (zh) * | 2012-07-25 | 2014-02-12 | 上海纽卓生物科技有限公司 | 胶体金法丙型肝炎病毒(hcv)快速诊断试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101266248A (zh) | 丙型肝炎病毒(HCV)IgM抗体快速检测试纸 | |
CN101149385A (zh) | 一种丙型肝炎病毒抗体快速诊断试纸及其制备方法 | |
CN1894584B (zh) | 同时进行血型测定、血清交叉核对和抗体检测试验的装置和方法 | |
KR102566305B1 (ko) | 개선된 분석물 검출을 위한 분석 방법 | |
CN201965131U (zh) | 一种甲型肝炎病毒IgM抗体快速检测试纸 | |
EP1327885B1 (en) | A kit for the simultaneous diagnosis of a plurality of infectious diseases and a method for preparation of it | |
CN101266246A (zh) | 人类免疫缺陷病毒(hiv)抗体和抗原联合快速检测试剂盒 | |
CN107942061A (zh) | 一种检测猪传染性胃肠炎病毒抗体的试纸卡、制备及其检测方法 | |
CN101377493A (zh) | 肾综合征出血热诊断试纸条、制备方法及检测试剂盒 | |
CN102109519A (zh) | 风疹病毒IgG、IgM抗体联检试剂盒及其制备方法 | |
CN201413329Y (zh) | 爱泼斯坦-巴尔病毒衣壳抗原和胸苷激酶蛋白免疫球蛋白a抗体联合检测试纸 | |
CN202149901U (zh) | 甲型肝炎病毒IgM和IgG抗体联合检测试纸 | |
CN101788562A (zh) | 甲型h1n1流感病毒总抗体快速检测试纸 | |
CN102109523A (zh) | 丙型肝炎病毒IgG、IgM抗体联检试剂盒及其制备方法 | |
CN102854316A (zh) | 一种甲型肝炎病毒IgM和IgG抗体胶体金法检测试剂盒 | |
CN105753981B (zh) | 抗人呼吸道合胞病毒n蛋白抗体及应用该抗体的免疫层析试剂盒 | |
CN101738476B (zh) | 乙肝病毒前s1抗原快速诊断试剂盒及其制备方法 | |
CN106188248A (zh) | 一种eb病毒抗原制备方法及利用该抗原制备的检测eb病毒抗体的快速检测试剂盒 | |
CN1740794B (zh) | 横向流动检测生物标本中特异性抗体的方法及其检测装置 | |
CN202182882U (zh) | 巨细胞病毒IgM和IgG抗体联合检测试纸 | |
CN201331529Y (zh) | 丙型肝炎病毒IgM抗体快速检测试纸 | |
CN108931644B (zh) | 一种口蹄疫病毒免疫抗体评价及感染与免疫鉴别诊断二联试纸条 | |
CN101358972A (zh) | 检测一种或多种猪病毒性腹泻疾病抗体的试纸条 | |
CN202153226U (zh) | 风疹病毒IgM和IgG抗体联合检测试纸 | |
CN101788561A (zh) | 甲型H1N1流感病毒IgM和总抗体快速检测试纸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Test paper for short-term hepatitis C virus (HCV) IgM antibody tests Effective date of registration: 20120517 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000211 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130307 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000211 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Test paper for short-term hepatitis C virus (HCV) IgM antibody tests Effective date of registration: 20130307 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2013990000126 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140126 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2013990000126 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Test paper for short-term hepatitis C virus (HCV) IgM antibody tests Effective date of registration: 20140212 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141231 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Test paper for short-term hepatitis C virus (HCV) IgM antibody tests Effective date of registration: 20150204 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160307 Granted publication date: 20091021 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300457 Binhai New Area, Tianjin economic and Technological Development Zone, No. sixth main street, No. 65 Patentee after: Tianjin new torch bio pharmaceutical Limited by Share Ltd Address before: 300150 Tianjin Development Zone, Sixth Street, No. 65 Patentee before: Newscen Coast Bio-Pharmaceutical Co., Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20091021 |